Saxenda 6 mg/mL solution for injection in pre-filled pen clinical trials

C5541010 - A PHASE 2A, RANDOMIZED, DOUBLE BLIND, SPONSOR OPEN, PLACEBO CONTROLLED, PARALLEL GROUP, DOSE-RANGING STUDY OF PF 07976016 TO ASSESS SAFETY AND EFFICACY IN ADULT PARTICIPANTS WITH OBESITY

This study is testing a new medicine, PF-07976016, to see if it helps adults with obesity lose weight safely. Participants will receive either the new medicine, a proven weight-loss drug called Saxenda, or a dummy medicine, to compare the effects.